CN113317428B - Calcium, iron and zinc solid preparation and preparation method thereof - Google Patents
Calcium, iron and zinc solid preparation and preparation method thereof Download PDFInfo
- Publication number
- CN113317428B CN113317428B CN202110668190.4A CN202110668190A CN113317428B CN 113317428 B CN113317428 B CN 113317428B CN 202110668190 A CN202110668190 A CN 202110668190A CN 113317428 B CN113317428 B CN 113317428B
- Authority
- CN
- China
- Prior art keywords
- calcium
- zinc
- iron
- parts
- source
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 title claims abstract description 96
- 229910052742 iron Inorganic materials 0.000 title claims abstract description 48
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title claims abstract description 46
- 239000011575 calcium Substances 0.000 title claims abstract description 46
- 229910052791 calcium Inorganic materials 0.000 title claims abstract description 46
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 title claims abstract description 41
- 239000011701 zinc Substances 0.000 title claims abstract description 38
- 229910052725 zinc Inorganic materials 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title claims abstract description 35
- 239000007787 solid Substances 0.000 title claims abstract description 29
- 229920000858 Cyclodextrin Polymers 0.000 claims abstract description 42
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 42
- JYMOQWNEIZBVFC-UHFFFAOYSA-N [Fe].[Zn].[Ca] Chemical compound [Fe].[Zn].[Ca] JYMOQWNEIZBVFC-UHFFFAOYSA-N 0.000 claims abstract description 34
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims abstract description 33
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 28
- 239000000843 powder Substances 0.000 claims abstract description 23
- GIPOFCXYHMWROH-UHFFFAOYSA-L 2-aminoacetate;iron(2+) Chemical group [Fe+2].NCC([O-])=O.NCC([O-])=O GIPOFCXYHMWROH-UHFFFAOYSA-L 0.000 claims abstract description 19
- 229940034055 calcium aspartate Drugs 0.000 claims abstract description 18
- 229940071566 zinc glycinate Drugs 0.000 claims abstract description 17
- UOXSXMSTSYWNMH-UHFFFAOYSA-L zinc;2-aminoacetate Chemical group [Zn+2].NCC([O-])=O.NCC([O-])=O UOXSXMSTSYWNMH-UHFFFAOYSA-L 0.000 claims abstract description 17
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 16
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 16
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 16
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 16
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 14
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims abstract description 14
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 14
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 14
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229940013618 stevioside Drugs 0.000 claims abstract description 14
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000019202 steviosides Nutrition 0.000 claims abstract description 14
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 14
- 239000011718 vitamin C Substances 0.000 claims abstract description 14
- 239000000811 xylitol Substances 0.000 claims abstract description 14
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 14
- 235000010447 xylitol Nutrition 0.000 claims abstract description 14
- 229960002675 xylitol Drugs 0.000 claims abstract description 14
- 235000021552 granulated sugar Nutrition 0.000 claims abstract description 11
- OPSXJNAGCGVGOG-DKWTVANSSA-L Calcium L-aspartate Chemical group [Ca+2].[O-]C(=O)[C@@H](N)CC([O-])=O OPSXJNAGCGVGOG-DKWTVANSSA-L 0.000 claims abstract 2
- 238000002156 mixing Methods 0.000 claims description 14
- 238000001035 drying Methods 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 238000000227 grinding Methods 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000001116 FEMA 4028 Substances 0.000 claims description 7
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 7
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 7
- 229960004853 betadex Drugs 0.000 claims description 7
- 239000011230 binding agent Substances 0.000 claims description 7
- 238000009835 boiling Methods 0.000 claims description 7
- 238000000643 oven drying Methods 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 4
- 239000002002 slurry Substances 0.000 claims description 4
- 235000005976 Citrus sinensis Nutrition 0.000 claims description 3
- 240000002319 Citrus sinensis Species 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 235000015165 citric acid Nutrition 0.000 claims description 3
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 claims description 2
- 241000167854 Bourreria succulenta Species 0.000 claims description 2
- 235000004936 Bromus mango Nutrition 0.000 claims description 2
- 240000007228 Mangifera indica Species 0.000 claims description 2
- 235000014826 Mangifera indica Nutrition 0.000 claims description 2
- 235000009184 Spondias indica Nutrition 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 2
- 239000000853 adhesive Substances 0.000 claims description 2
- 230000001070 adhesive effect Effects 0.000 claims description 2
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 claims description 2
- 229940043377 alpha-cyclodextrin Drugs 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000019693 cherries Nutrition 0.000 claims description 2
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 claims description 2
- 229940080345 gamma-cyclodextrin Drugs 0.000 claims description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 239000000463 material Substances 0.000 abstract description 6
- 235000019629 palatability Nutrition 0.000 abstract description 4
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 abstract description 3
- 229940009098 aspartate Drugs 0.000 abstract description 3
- OFNJDDJDXNMTHZ-UHFFFAOYSA-L calcium;2-aminoacetate Chemical compound [Ca+2].NCC([O-])=O.NCC([O-])=O OFNJDDJDXNMTHZ-UHFFFAOYSA-L 0.000 abstract description 3
- 229940062776 zinc aspartate Drugs 0.000 abstract description 3
- POEVDIARYKIEGF-CEOVSRFSSA-L zinc;(2s)-2-aminobutanedioate;hydron Chemical compound [Zn+2].[O-]C(=O)[C@@H](N)CC(O)=O.[O-]C(=O)[C@@H](N)CC(O)=O POEVDIARYKIEGF-CEOVSRFSSA-L 0.000 abstract description 3
- 239000000825 pharmaceutical preparation Substances 0.000 abstract description 2
- 229960005069 calcium Drugs 0.000 description 36
- GYUKEMYHXWICKF-DKWTVANSSA-N (2s)-2-aminobutanedioic acid;calcium Chemical group [Ca].OC(=O)[C@@H](N)CC(O)=O GYUKEMYHXWICKF-DKWTVANSSA-N 0.000 description 16
- 238000010521 absorption reaction Methods 0.000 description 13
- 239000008187 granular material Substances 0.000 description 13
- 230000000052 comparative effect Effects 0.000 description 12
- 229960004494 calcium gluconate Drugs 0.000 description 11
- 239000004227 calcium gluconate Substances 0.000 description 11
- 235000013927 calcium gluconate Nutrition 0.000 description 11
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 11
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 10
- 239000004222 ferrous gluconate Substances 0.000 description 10
- 235000013924 ferrous gluconate Nutrition 0.000 description 10
- 229960001645 ferrous gluconate Drugs 0.000 description 10
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 10
- 235000011478 zinc gluconate Nutrition 0.000 description 10
- 239000011670 zinc gluconate Substances 0.000 description 10
- 229960000306 zinc gluconate Drugs 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 210000002966 serum Anatomy 0.000 description 7
- 235000013361 beverage Nutrition 0.000 description 6
- 238000007599 discharging Methods 0.000 description 5
- 238000005507 spraying Methods 0.000 description 5
- 235000013305 food Nutrition 0.000 description 4
- 229960003284 iron Drugs 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 3
- 206010048259 Zinc deficiency Diseases 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 229910001448 ferrous ion Inorganic materials 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 206010006956 Calcium deficiency Diseases 0.000 description 2
- 206010022971 Iron Deficiencies Diseases 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 2
- 239000013522 chelant Substances 0.000 description 2
- 238000005034 decoration Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940024464 emollients and protectives zinc product Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 206010058314 Dysplasia Diseases 0.000 description 1
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 1
- 206010070538 Gestational hypertension Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000018678 bone mineralization Effects 0.000 description 1
- 229940043430 calcium compound Drugs 0.000 description 1
- 150000001674 calcium compounds Chemical class 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229910001447 ferric ion Inorganic materials 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229940082629 iron antianemic preparations Drugs 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 201000011461 pre-eclampsia Diseases 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940120347 zinc preparations Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/09—Mashed or comminuted products, e.g. pulp, purée, sauce, or products made therefrom, e.g. snacks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/42—Preservation of non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
- A23L3/3562—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A23L33/165—Complexes or chelates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention relates to the technical field of pharmaceutical preparations, in particular to a calcium-iron-zinc solid preparation and a preparation method thereof. The calcium iron zinc solid preparation comprises the following raw and auxiliary materials in parts by weight: 1-50 parts of maltodextrin, 1-30 parts of cyclodextrin, 1-35 parts of fruit powder, 0.05-10 parts of iron source, 0.001-8 parts of zinc source, 1-30 parts of calcium source, 1-30 parts of xylitol, 1-20 parts of white granulated sugar, 0.01-4.0 parts of stevioside, 0.1-2 parts of vitamin C and 0.1-5 parts of citric acid; the iron source is ferrous glycinate and/or ferric aspartate; the zinc source is zinc glycinate and/or zinc aspartate; the calcium source is calcium aspartate and/or calcium glycinate. The calcium-iron-zinc solid preparation has better bioavailability and good palatability.
Description
Technical Field
The invention relates to the technical field of pharmaceutical preparations, in particular to a calcium-iron-zinc solid preparation and a preparation method thereof.
Background
The calcium, iron and zinc are important constituent elements of human body, and have special nutritive value and special physiological function. The calcium-iron-zinc deficiency is a series of diseases caused by the deficiency of calcium, iron and zinc, and is particularly suitable for special people such as the old, infants, pregnant women and the like. Has become a serious social health problem worldwide. Calcium deficiency is mainly manifested in children's hypoevolutism, abnormal cartilage structure, and bone calcification disorder, and rickets (bone deformation, tooth dysplasia, etc.) appear. The lack of calcium in pregnant women can cause the slow development of fetuses and influence the growth after birth, which causes children to be easy to have convulsion, X-shaped legs and O-shaped legs, and also causes pregnant women to have gestational hypertension and postpartum osteoporosis. The effect on the elderly is osteoporosis. Iron deficiency can cause hemoglobin reduction, reduce the immunity of a human body and also cause a series of chronic diseases, zinc is an important trace element of the human body, and the deficiency can cause low immunity, reduced learning ability and anorexia to cause serious consequences.
According to the evaluation of the dietary calcium intake condition of Chinese residents in 2000-2007, the average daily calcium intake of Chinese residents is less than 50% of the proper intake, and according to the investigation and statistics of the current situation of nutrition and health of Chinese residents in 2004, the prevalence rate of anemia is 15.2% on average, and nutritional iron-deficiency anemia of infants, pregnant women and old people is more serious. The intake of zinc is 53.3 percent and 45.3 percent of the average demand of Chinese urban residents and rural residents.
At present, the calcium, iron and zinc products on the market are more, mainly oral liquid, tablets and granules, and are compatible with inorganic calcium, calcium gluconate, iron and zinc, so that the product has low absorptivity and low bioavailability, and the absorption mechanisms have mutual competition. Data research shows that calcium has absorption inhibition effect on the absorption of iron and zinc in general.
Most of the calcium, iron and zinc products on the market have single process and are not processed, and the adopted iron supplements are compounds with iron fishy smell and severe gastrointestinal reaction, so that the calcium, iron, zinc and calcium compounds are not easy to accept for pregnant women in pregnancy reaction period and infants with more delicate taste. The gastrointestinal function of the old is further degraded due to the degradation of the body, and the preparation with strong gastrointestinal reaction is not suitable. People who lack calcium, iron and zinc are particularly important to the three groups, so that the people can be provided with products with ideal taste and effect by adopting a relatively advanced process and proper compatibility.
Therefore, the research and development of the calcium, iron and zinc supplementing granules which can mask the bad taste of iron fishy smell and the like, are easy to absorb and are easy to accept by users, can be prepared into reinforced solid beverages and health-care foods, have good palatability and small irritation to the gastrointestinal tract, are suitable for pregnant women, infants and the old, and are social requirements.
Disclosure of Invention
In view of the above, the invention provides a calcium-iron-zinc solid preparation and a preparation method thereof. The calcium, iron and zinc solid preparation has good bioavailability and palatability.
In order to achieve the above object, the present invention provides the following technical solutions:
the invention provides a calcium-iron-zinc solid preparation, which comprises the following raw and auxiliary materials in parts by weight:
1-50 parts of maltodextrin, 1-30 parts of cyclodextrin, 1-35 parts of fruit powder, 0.05-10 parts of iron source, 0.001-8 parts of zinc source, 1-30 parts of calcium source, 1-30 parts of xylitol, 1-20 parts of white granulated sugar, 0.01-4.0 parts of stevioside, 0.1-2 parts of vitamin C and 0.1-5 parts of citric acid;
the iron source is ferrous glycinate and/or ferric aspartate;
the zinc source is zinc glycinate and/or zinc aspartate;
the calcium source is calcium aspartate and/or calcium glycinate.
The invention relates to a particle supplement for people with calcium, iron and zinc deficiency in the field of food and health-care food, which can safely and effectively supplement three elements of calcium, iron and zinc. The research shows that calcium can competitively inhibit the absorption of iron and zinc, the amino acid chelate is used as a calcium-iron-zinc donor, and the cyclodextrin inclusion technology is adopted, so that the absorption of the amino acid chelate can be obviously improved, the cyclodextrin inclusion compound has the effect of mutually promoting the absorption, and the symptom of calcium-iron-zinc deficiency can be quickly improved. The product has good solubility and tastes sour, sweet and delicious.
The invention mainly solves the problem of larger iron fishy smell of calcium, iron and zinc supplementing particles, the three nutrient elements necessary for human bodies, namely calcium, iron and zinc, can be mutually promoted to be absorbed, and each nutrient element has good absorption and high utilization rate, particularly the absorption of calcium, and has better bioavailability and better palatability under the condition of no vitamin D.
Preferably, the calcium, iron and zinc solid preparation comprises the following raw and auxiliary materials in parts by weight:
40-50 parts of maltodextrin, 10-20 parts of cyclodextrin, 10-20 parts of fruit powder, 0.1-1 part of iron source, 0.01-0.1 part of zinc source, 5-15 parts of calcium source, 5-15 parts of xylitol, 1-10 parts of white granulated sugar, 0.1-1 part of stevioside, 0.1-2 parts of vitamin C and 0.1-2 parts of citric acid.
In the specific embodiment provided by the invention, the calcium-iron-zinc solid preparation comprises the following raw and auxiliary materials in parts by weight:
45 parts of maltodextrin, 15 parts of cyclodextrin, 17 parts of fruit powder, 0.12 part of iron source, 0.065 part of zinc source, 10 parts of calcium source, 8 parts of xylitol, 3.6 parts of white granulated sugar, 0.215 part of stevioside, 1 parts of vitamin C and 1 part of citric acid.
Preferably, the cyclodextrin is one or more of alpha-cyclodextrin, beta-cyclodextrin and gamma-cyclodextrin.
Preferably, the DE value of the maltodextrin is 15-20.
Preferably, the fruit powder is selected from, but not limited to, sweet orange powder, mango powder, cherry powder.
The invention also provides a preparation method of the calcium-iron-zinc solid preparation, which comprises the following steps:
mixing cyclodextrin with iron source, zinc source and calcium source, and grinding to obtain cyclodextrin calcium iron zinc clathrate;
mixing cyclodextrin calcium-iron-zinc clathrate, maltodextrin, fruit powder, xylitol, white sugar, stevioside, vitamin C, and citric acid, adding adhesive, granulating, and drying to water content below 2%.
Preferably, the time for polishing is 2 to 10 hours.
Preferably, the binder is selected from, but not limited to, water, ethanol solution, sodium carboxymethyl cellulose slurry, starch slurry.
Preferably, the drying is boiling drying and/or oven drying.
The invention provides a calcium-iron-zinc solid preparation and a preparation method thereof. The calcium iron zinc solid preparation comprises the following raw and auxiliary materials in parts by weight: 1-50 parts of maltodextrin, 1-30 parts of cyclodextrin, 1-35 parts of fruit powder, 0.05-10 parts of iron source, 0.001-8 parts of zinc source, 1-30 parts of calcium source, 1-30 parts of xylitol, 1-20 parts of white granulated sugar, 0.01-4.0 parts of stevioside, 0.1-2 parts of vitamin C and 0.1-5 parts of citric acid; the iron source is ferrous glycinate and/or ferric aspartate; the zinc source is zinc glycinate and/or zinc aspartate; the calcium source is calcium aspartate and/or calcium glycinate. The invention has the technical effects that:
the calcium, iron and zinc are synergistically supplemented by taking ferrous glycinate, zinc glycinate and calcium aspartate as raw materials, the effect is good compared with other calcium, iron and zinc preparations, the index is improved quickly, and the increase is obvious.
In the formula of the calcium-iron-zinc granules, cyclodextrin inclusion technology and amino acid chelated calcium-iron-zinc, fruit powder and other raw materials are adopted, so that the calcium-iron-zinc granules have the advantages of solubility, comfortable mouthfeel, no competitive absorption of the three components, no influence on respective absorption, good absorption and small iron fishy smell. And has the effect of promoting absorption mutually.
The method adopts a grinding method to include the molecules of zinc ferrous glycinate, ferrous glycinate and calcium aspartate into the cavity of the cyclodextrin, thereby avoiding the exposure of calcium, iron and zinc ions, avoiding the damage of the calcium, iron and zinc ions by phytic acid substances in food and the action of gastric acid, protecting the emission of iron fishy smell of ferrous ions in the process of taking, and simultaneously protecting the contact of the ferrous ions and oxygen in the air, so that the ferrous ions are not easily oxidized into ferric ions to lose the effect.
Detailed Description
The invention discloses a calcium-iron-zinc solid preparation and a preparation method thereof, and a person skilled in the art can realize the preparation by properly improving process parameters by referring to the content. It is expressly intended that all such similar substitutes and modifications which would be obvious to one skilled in the art are deemed to be included in the invention. While the methods and applications of this invention have been described in terms of preferred embodiments, it will be apparent to those of ordinary skill in the art that variations and modifications in the methods and applications described herein, as well as other suitable variations and combinations, may be made to implement and use the techniques of this invention without departing from the spirit and scope of the invention.
The raw materials or auxiliary materials used in the invention can be purchased from the market.
The invention is further illustrated by the following examples:
example 1
The formula of the calcium, iron and zinc granules in the embodiment comprises the following components in parts by weight:
45 parts of maltodextrin (DE value of 20), 15 parts of beta-cyclodextrin, 17 parts of sweet orange powder, 0.12 part of ferrous glycinate, 0.065 part of zinc glycinate, 10 parts of calcium aspartate, 8 parts of xylitol, 3.6 parts of white granulated sugar, 0.215 part of stevioside, 1 part of vitamin C and 1 part of citric acid.
The preparation method comprises the following steps:
mixing cyclodextrin with ferrous glycinate, zinc glycinate and calcium aspartate, and grinding to obtain cyclodextrin calcium iron zinc clathrate;
mixing cyclodextrin calcium-iron-zinc clathrate, maltodextrin, fruit powder, xylitol, white sugar, stevioside, vitamin C and citric acid, spraying appropriate amount of binder (4 parts of 50% alcohol), boiling, drying for 1 hr, oven drying at 60 deg.C for 90 min until water content is below 2%, and discharging to obtain granule.
Comparative example 1
The formula of the calcium iron zinc granule of the comparative example comprises the following components in parts by weight:
45 parts of maltodextrin, 15 parts of beta-cyclodextrin, 17 parts of fruit powder, 0.2 part of ferrous gluconate, 0.065 part of zinc glycinate, 10 parts of calcium aspartate, 8 parts of xylitol, 3.6 parts of white granulated sugar, 0.215 part of stevioside, 1 part of vitamin C and 1 part of citric acid.
Mixing cyclodextrin with ferrous gluconate, zinc glycinate and calcium aspartate, and grinding to obtain cyclodextrin ferrous gluconate, zinc glycinate and calcium aspartate clathrate;
mixing cyclodextrin ferrous gluconate, zinc glycinate, calcium aspartate clathrate and other components, spraying appropriate amount of binder (4 parts of 50% alcohol), boiling, drying for 1 hr, oven drying at 60 deg.C for 90 min until water content is below 2%, and discharging to obtain granule.
Comparative example 2
The formula of the calcium iron zinc granule of the comparative example comprises the following components in parts by weight:
45 parts of maltodextrin, 15 parts of beta-cyclodextrin, 17 parts of fruit powder, 0.12 part of ferrous glycinate, 0.15 part of zinc gluconate, 10 parts of calcium aspartate, 8 parts of xylitol, 3.6 parts of white granulated sugar, 0.215 part of stevioside, 1 part of vitamin C and 1 part of citric acid.
Mixing cyclodextrin with ferrous glycinate, zinc gluconate and calcium aspartate, and grinding to obtain cyclodextrin ferrous glycinate, zinc gluconate and calcium aspartate clathrate;
mixing cyclodextrin ferrous glycinate, zinc gluconate, calcium aspartate clathrate and other components, spraying appropriate amount of binder (4 parts of 50% alcohol), boiling, drying for 1 hr, oven drying at 60 deg.C for 90 min until water content is below 2%, and discharging to obtain granule.
Comparative example 3
The formula of the calcium iron zinc granule of the comparative example comprises the following components in parts by weight:
45 parts of maltodextrin, 15 parts of beta-cyclodextrin, 17 parts of fruit powder, 0.12 part of ferrous glycinate, 0.065 part of zinc glycinate, 13.7 parts of calcium gluconate, 8 parts of xylitol, 3.6 parts of white granulated sugar, 0.215 part of stevioside, 1 part of vitamin C and 1 part of citric acid.
Mixing cyclodextrin with ferrous glycinate, zinc glycinate and calcium gluconate, and grinding to obtain cyclodextrin ferrous glycinate, zinc glycinate and calcium gluconate clathrate;
mixing cyclodextrin ferrous glycinate, zinc glycinate, calcium gluconate clathrate and the rest components, spraying appropriate amount of binder (4 parts of 50% alcohol), boiling, drying for 1 hr, oven drying at 60 deg.C for 90 min until water content is below 2%, and discharging to obtain granule.
Comparative example 4
The formula of the calcium iron zinc granule of the comparative example comprises the following components in parts by weight:
45 parts of maltodextrin, 15 parts of beta-cyclodextrin, 17 parts of fruit powder, 0.2 part of ferrous gluconate, 0.15 part of zinc gluconate, 13.7 parts of calcium gluconate, 8 parts of xylitol, 3.6 parts of white granulated sugar, 0.215 part of stevioside, 1 part of vitamin C and 1 part of citric acid.
Mixing cyclodextrin with ferrous gluconate, zinc gluconate and calcium gluconate, and grinding to obtain cyclodextrin inclusion compound containing ferrous gluconate, zinc gluconate and calcium gluconate;
mixing cyclodextrin ferrous gluconate, zinc gluconate, calcium gluconate clathrate and other components, spraying appropriate amount of binder (4 parts of 50% alcohol), boiling, drying for 1 hr, oven drying at 60 deg.C for 90 min until water content is below 2%, and discharging to obtain granule.
Verification example
100 children with serum iron, serum calcium and serum zinc lower than normal values are selected as testees. The test population was divided into five groups of 20 persons each: the control group is the population taking the calcium-iron-zinc fortified solid beverage prepared by using ferrous gluconate to replace ferrous glycinate in the comparative example 1; the control group is the group taking the fortified solid beverage prepared by replacing zinc glycinate with zinc gluconate in comparative example 2; the control three groups are the population taking the calcium-iron-zinc fortified solid beverage prepared by using the calcium gluconate to replace the calcium aspartate in the comparative example 3; the four groups of control groups are the groups taking the fortified solid beverage prepared by using ferrous gluconate, zinc gluconate and calcium gluconate to replace ferrous glycinate, zinc glycinate and calcium aspartate in the comparative example 4; the group of subjects who took the calcium-iron-zinc fortified solid beverage prepared in example 1. Each group was taken three times a day, one bag each time, 15g each bag, 5mL venous blood was extracted from the abdomen of 30 days, 60 days and 90 days, serum calcium, iron and zinc were measured once each with atomic absorption spectrophotometer, all data were averaged and the results are shown in table 1:
TABLE 1
(unit: serum calcium mmol/L, serum zinc. mu. mol/L, serum iron. mu.g/dl)
The foregoing is only a preferred embodiment of the present invention, and it should be noted that, for those skilled in the art, various modifications and decorations can be made without departing from the principle of the present invention, and these modifications and decorations should also be regarded as the protection scope of the present invention.
Claims (7)
1. The calcium-iron-zinc solid preparation is characterized by comprising the following raw materials in parts by weight:
45 parts of maltodextrin, 15 parts of cyclodextrin, 17 parts of fruit powder, 0.12 part of iron source, 0.065 part of zinc source, 10 parts of calcium source, 8 parts of xylitol, 3.6 parts of white granulated sugar, 0.215 part of stevioside, 1 part of vitamin C and 1 part of citric acid;
the iron source is ferrous glycinate;
the zinc source is zinc glycinate;
the calcium source is calcium aspartate;
the preparation method of the calcium-iron-zinc solid preparation comprises the following steps:
mixing cyclodextrin with iron source, zinc source and calcium source, and grinding to obtain cyclodextrin calcium iron zinc clathrate;
mixing cyclodextrin calcium-iron-zinc clathrate, maltodextrin, fruit powder, xylitol, white sugar, stevioside, vitamin C, and citric acid, adding adhesive, granulating, and drying to water content below 2%.
2. The solid preparation of calcium, iron and zinc as claimed in claim 1, wherein the cyclodextrin is one or more of α -cyclodextrin, β -cyclodextrin and γ -cyclodextrin.
3. The calcium-iron-zinc solid preparation according to claim 1, wherein the DE value of maltodextrin is 15 to 20.
4. The calcium-iron-zinc solid preparation according to any one of claims 1 to 3, wherein the fruit powder is selected from but not limited to sweet orange powder, mango powder and cherry powder.
5. The solid preparation of calcium, iron and zinc according to claim 1, wherein the time for grinding is 2 to 10 hours.
6. The solid preparation of calcium, iron and zinc as claimed in claim 1, wherein the binder is selected from the group consisting of water, ethanol solution, sodium carboxymethyl cellulose slurry, starch slurry.
7. The solid preparation of calcium, iron and zinc according to claim 1, wherein the drying is boiling drying and/or oven drying.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110668190.4A CN113317428B (en) | 2021-06-16 | 2021-06-16 | Calcium, iron and zinc solid preparation and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110668190.4A CN113317428B (en) | 2021-06-16 | 2021-06-16 | Calcium, iron and zinc solid preparation and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113317428A CN113317428A (en) | 2021-08-31 |
CN113317428B true CN113317428B (en) | 2022-08-09 |
Family
ID=77423319
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110668190.4A Active CN113317428B (en) | 2021-06-16 | 2021-06-16 | Calcium, iron and zinc solid preparation and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113317428B (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101044915A (en) * | 2006-03-31 | 2007-10-03 | 上海医药工业研究院 | Effervescence type solid beverage containing amino-acid chaleted calcium and zinc and its preparing method |
CN101279089A (en) * | 2007-04-05 | 2008-10-08 | 新疆华世丹药业有限公司 | Donkey-hide gelatin calcium composition and preparing process thereof |
CA2826179A1 (en) * | 2011-02-17 | 2012-08-23 | Isf Gmbh | Method for producing amino acid chelate compounds, amino acid chelate compounds and use of amino acid chelate compounds |
CN103690559A (en) * | 2014-01-05 | 2014-04-02 | 刘春华 | Formulation form of supplement calcium, magnesium, iron, zinc and iodine, and oral liquid preparation method of formulation |
CN105687204A (en) * | 2016-04-15 | 2016-06-22 | 石家庄东华金龙化工有限公司 | Glycine metal chelate complex and preparation method thereof |
US10039805B1 (en) * | 2016-02-26 | 2018-08-07 | Michelle Ann Toothman | Infant formulas having vitamin complexes with enhanced bioavailability |
CN112675160A (en) * | 2020-12-31 | 2021-04-20 | 河北力维素科技有限公司 | Amino acid mineral salt trace element composition and preparation method thereof |
-
2021
- 2021-06-16 CN CN202110668190.4A patent/CN113317428B/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101044915A (en) * | 2006-03-31 | 2007-10-03 | 上海医药工业研究院 | Effervescence type solid beverage containing amino-acid chaleted calcium and zinc and its preparing method |
CN101279089A (en) * | 2007-04-05 | 2008-10-08 | 新疆华世丹药业有限公司 | Donkey-hide gelatin calcium composition and preparing process thereof |
CA2826179A1 (en) * | 2011-02-17 | 2012-08-23 | Isf Gmbh | Method for producing amino acid chelate compounds, amino acid chelate compounds and use of amino acid chelate compounds |
CN103690559A (en) * | 2014-01-05 | 2014-04-02 | 刘春华 | Formulation form of supplement calcium, magnesium, iron, zinc and iodine, and oral liquid preparation method of formulation |
US10039805B1 (en) * | 2016-02-26 | 2018-08-07 | Michelle Ann Toothman | Infant formulas having vitamin complexes with enhanced bioavailability |
CN105687204A (en) * | 2016-04-15 | 2016-06-22 | 石家庄东华金龙化工有限公司 | Glycine metal chelate complex and preparation method thereof |
CN112675160A (en) * | 2020-12-31 | 2021-04-20 | 河北力维素科技有限公司 | Amino acid mineral salt trace element composition and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
Soldier crab (Mictyris brevidactylus), a resource of nutritional food material;Tian-Tian Liu et al.;《JOURNAL OF APPLIED ANIMAL RESEARCH》;20201231;第48卷(第1期);第109-113页 * |
钙、铁、锌相互作用关系的研究进展;任典旭;《国外医学卫生学分册》;19961231;第23卷(第5期);第289-291页 * |
Also Published As
Publication number | Publication date |
---|---|
CN113317428A (en) | 2021-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4994283A (en) | Iron-calcium mineral supplements with enhanced bioavailability | |
US5118513A (en) | Method for enhancing bioavailability of iron-calcium mineral supplements | |
EP0297680B1 (en) | Iron mineral supplements | |
AU609675B2 (en) | Calcium-iron mineral supplements | |
WO1999042096A1 (en) | Composition comprising theanine | |
JP2983503B2 (en) | Iron-calcium mineral supplement with high bioavailability | |
US7829127B2 (en) | Fortification of syrup with calcium and other minerals and vitamins | |
EP2330924A1 (en) | Iron-containing nutritional supplement | |
JPH08503127A (en) | A concentrated bioavailable calcium source | |
CN103432161A (en) | Multivitamin mineral effervescent tablet and preparation method thereof | |
KR101896024B1 (en) | Functional food compositions comprising extracts of Garcinia Cambogia as active ingredients and method for preparing the same | |
KR20020006114A (en) | Manufacturing Method of Absorptive Zinc-Oligopeptide in The Human Body | |
JPH0272843A (en) | Mineral supplement containing sugar alcohol | |
CN113317428B (en) | Calcium, iron and zinc solid preparation and preparation method thereof | |
JP2000189109A (en) | Liquid food | |
JP2001269135A (en) | Nutritional composition capable of promoting body protein accumulation efficiency | |
KR100763491B1 (en) | Garlic product reduced a smell of garlic and garlic juice thereof | |
US20240034744A1 (en) | Complex compound of comprising the citrate and iron ion and the food composition comprising the same | |
JP7072930B2 (en) | Ferulic acid-containing beverage | |
RU2776298C1 (en) | Biologically active food additives based on ascorbic acid and stevia extract | |
JP2018000157A (en) | Ferulic acid-containing beverage | |
CN1303904C (en) | Olive calcium tablet | |
KR101306931B1 (en) | Preparation method for milk protein with high content of organic calcium | |
US20220312813A1 (en) | Formulation for iron supplements | |
JPH0380054A (en) | Calcium enriching agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |